Poseida Therapeutics, Inc.

PSTXDelisted Jan 8, 2025

Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001661460

SEC filings (opens in a new tab)

Poseida Therapeutics, Inc. was delisted on Jan 8, 2025; its insiders filed their last Form 4 on Jan 10, 2025; 116 institutions reported holding it in 13F filings for Q4 2024, worth $519.2M in total; no superinvestor held it.

Holders of 5% or more of PSTX

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Poseida Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of Poseida Therapeutics, Inc. on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

6 Schedule 13D and 13G filings on Poseida Therapeutics, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on PSTX
Filed (ET)	Filer	Form	Stake	Change	Event date	Filing
May 15, 20254:36 PM ET	Nomura Holdings Incand 1 other	13G/A	0.00%0 shares	−5.20 ppfrom 5.20%Below 5%	Mar 31, 2025	SEC
Feb 14, 20254:54 PM ET	Nomura Holdings Incand 1 other	13G	5.20%5.12M shares	New	Dec 31, 2024	SEC
Feb 7, 202510:23 AM ET	FMR LLCand 1 other	13G/A	0.00%0 shares	−10.30 ppfrom 10.30%Below 5%	Jan 31, 2025	SEC
Feb 7, 202510:06 AM ET	FMR LLCand 1 other	13G/A	10.30%10.0M shares	–	Dec 31, 2024	SEC
Jan 15, 20254:27 PM ET	Malin Life Sciences Holdings Ltdand 1 other	13G/A	0.00%0 shares	–Below 5%	Jan 8, 2025	SEC
Jan 13, 20254:05 PM ET	Pentwater Capital Management LPand 1 other	13D/A	0.00%0 shares	–Below 5%	Jan 8, 2025	SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Poseida Therapeutics, Inc. shares.

No Form 144 notices for Poseida Therapeutics, Inc. are on file.